JP Morgan Upgrades InterMune To Overweight, Raises PT To $45
JP Morgan has upgraded InterMune (NASDAQ: ITMN) from Neutral to Overweight and has raised the price target from $38 to $45.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: InterMune JP MorganUpgrades Price Target Analyst Ratings